TY - JOUR
T1 - Characterizing the longitudinal relations between depressive and menstrual symptoms in adolescent girls
AU - Beal, Sarah J.
AU - Dorn, Lorah D.
AU - Sucharew, Heidi J.
AU - Sontag-Padilla, Lisa
AU - Pabst, Stephanie
AU - Hillman, Jennifer
N1 - Publisher Copyright:
Copyright © 2014 by the American Psychosomatic Society.
PY - 2014
Y1 - 2014
N2 - Objective: This study examined the association between depressive and menstrual symptoms in adolescent girls in a 3-year longitudinal study. It was hypothesized that menstrual symptoms would increase in early adolescence and decrease in later adolescence, that girls with greater depressive symptoms would report greater menstrual symptoms, and that effects would persist after adjusting for general somatic complaints.Methods: A community sample of girls (n = 262) enrolled in an observational study by age cohort (11, 13, 15, 17 years) completed three annual visits. At each time point, girls completed the Menstrual Symptom Questionnaire, Children's Depression Inventory, and the Youth Self Report to assess general somatic complaints.Results: Menstrual symptoms increased significantly across adolescence (p =.006) and began to plateau in later adolescence (p =.020). Depressive symptoms at study entry were significantly associated with menstrual symptoms (p <.001). When general somatic complaints were included in the models, the effect of depressive symptoms on menstrual symptoms remained significant for the sum score (p =.015) and the menstrual somatic symptoms subscale (p =.001). After adjusting for somatic complaints, initial report of depressive symptoms predicted change in menstrual symptoms only for girls with the lowest menstrual symptoms sum score (p =.025). Initial report of somatic complaints predicted change in menstrual symptoms (p =.020).Conclusions: Girls with higher depressive symptoms and higher somatic complaints are at greater risk for experiencing menstrual symptoms and increasing symptoms across adolescence, with a heightened vulnerability for girls with lower baseline menstrual symptoms.
AB - Objective: This study examined the association between depressive and menstrual symptoms in adolescent girls in a 3-year longitudinal study. It was hypothesized that menstrual symptoms would increase in early adolescence and decrease in later adolescence, that girls with greater depressive symptoms would report greater menstrual symptoms, and that effects would persist after adjusting for general somatic complaints.Methods: A community sample of girls (n = 262) enrolled in an observational study by age cohort (11, 13, 15, 17 years) completed three annual visits. At each time point, girls completed the Menstrual Symptom Questionnaire, Children's Depression Inventory, and the Youth Self Report to assess general somatic complaints.Results: Menstrual symptoms increased significantly across adolescence (p =.006) and began to plateau in later adolescence (p =.020). Depressive symptoms at study entry were significantly associated with menstrual symptoms (p <.001). When general somatic complaints were included in the models, the effect of depressive symptoms on menstrual symptoms remained significant for the sum score (p =.015) and the menstrual somatic symptoms subscale (p =.001). After adjusting for somatic complaints, initial report of depressive symptoms predicted change in menstrual symptoms only for girls with the lowest menstrual symptoms sum score (p =.025). Initial report of somatic complaints predicted change in menstrual symptoms (p =.020).Conclusions: Girls with higher depressive symptoms and higher somatic complaints are at greater risk for experiencing menstrual symptoms and increasing symptoms across adolescence, with a heightened vulnerability for girls with lower baseline menstrual symptoms.
UR - http://www.scopus.com/inward/record.url?scp=84914153772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84914153772&partnerID=8YFLogxK
U2 - 10.1097/PSY.0000000000000099
DO - 10.1097/PSY.0000000000000099
M3 - Article
C2 - 25170752
AN - SCOPUS:84914153772
SN - 0033-3174
VL - 76
SP - 547
EP - 554
JO - Psychosomatic medicine
JF - Psychosomatic medicine
IS - 7
ER -